Search filters

List of works by Barbara Kiesewetter

18F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance in Lymphoma: Comparison With 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography and With the Addition of Magnetic Resonance Diffusion-Weighted Imaging

scientific article published on 18 January 2016

A phase 2 study of rituximab plus lenalidomide for mucosa-associated lymphoid tissue lymphoma

scientific article published on 22 November 2016

A phase II study of lenalidomide in patients with extranodal marginal zone B-cell lymphoma of the mucosa associated lymphoid tissue (MALT lymphoma).

scientific article published on 16 August 2012

A pilot phase II study of ofatumumab monotherapy for extranodal marginal zone B-cell lymphoma of the mucosa-associated lymphoid tissue (MALT) lymphoma

scientific article

A pilot study of confocal laser endomicroscopy for diagnosing gastrointestinal mucosa-associated lymphoid tissue (MALT) lymphoma

scientific article published on 20 October 2015

Antibiotic treatment as sole management of Helicobacter pylori-negative gastric MALT lymphoma: a single center experience with prolonged follow-up

scientific article published on 13 January 2015

Awareness of predatory journals and open access among medical oncologists: results of an online survey

scientific article published on 27 November 2019

CXCR4 PET/MRI for follow-up of gastric mucosa–associated lymphoid tissue lymphoma after first-line <i>Helicobacter pylori</i> eradication

scientific article published in 2022

Can Interim 18F-FDG PET or Diffusion-Weighted MRI Predict End-of-Treatment Outcome in FDG-Avid MALT Lymphoma After Rituximab-Based Therapy?: A Preliminary Study in 15 Patients

scientific article published on 16 September 2016

Chemoimmunotherapy for Mucosa-Associated Lymphoid Tissue-Type Lymphoma: A Review of the Literature.

scientific article published on 08 July 2015

Clarithromycin Leading to Complete Remission in the First-Line Treatment of Ocular Adnexal Mucosa-Associated Lymphoid Tissue Lymphoma

article

Clarithromycin as a "repurposing drug" against MALT lymphoma.

scientific article

Clinical activity of everolimus in relapsed/refractory marginal zone B-cell lymphomas: results of a phase II study of the International Extranodal Lymphoma Study Group

scientific article

Clinical features, treatment and outcome of mucosa-associated lymphoid tissue (MALT) lymphoma of the ocular adnexa: single center experience of 60 patients

scientific article

Clinicopathologic characteristics and treatment of marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma)

scientific article

Delayed Efficacy After Treatment With Lenalidomide or Thalidomide in Patients With Mucosa-Associated Lymphoid Tissue Lymphoma

scientific article

Depth of Remission Following First-Line Treatment Is an Independent Prognostic Marker for Progression-Free Survival in Gastric Mucosa-Associated Lymphoid Tissue (MALT) Lymphoma

scientific article published on 20 February 2020

Differential somatostatin and CXCR4 chemokine receptor expression in MALT-type lymphoma of gastric and extragastric origin.

scientific article published on 20 August 2016

Does Delayed-Time-Point Imaging Improve 18F-FDG-PET in Patients With MALT Lymphoma?: Observations in a Series of 13 Patients

scientific article

EHA evaluation of the ESMO-Magnitude of Clinical Benefit Scale version 1.1 (ESMO-MCBS v1.1) for haematological malignancies

scientific article published on 01 January 2020

Erratum to: Differential somatostatin and CXCR4 chemokine receptor expression in MALT-type lymphoma of gastric and extragastric origin

scientific article published on 01 January 2017

Evaluation of Diffusion-Weighted Magnetic Resonance Imaging for Follow-up and Treatment Response Assessment of Lymphoma: Results of an 18F-FDG-PET/CT-Controlled Prospective Study in 64 Patients

scientific article published on 2 March 2015

Evaluation of diffusion-weighted MRI for pretherapeutic assessment and staging of lymphoma: results of a prospective study in 140 patients

scientific article published on 2 April 2014

Experience with clarithromycin as antineoplastic therapy for extranodal marginal zone B-cell lymphoma of the mucosa associated lymphoid tissue (MALT-lymphoma) outside of clinical trials: Real-world data from the University of Vienna

scientific article published on 29 April 2020

First Line Systemic Treatment for MALT Lymphoma-Do We Still Need Chemotherapy? Real World Data from the Medical University Vienna

scientific article published on 26 November 2020

Gender Aspects in Extranodal Marginal Zone B-Cell Lymphoma of the Mucosa-Associated Lymphoid Tissue: Does Sex Matter?

scientific article published on 23 August 2016

High-dose clarithromycin is an active monotherapy for patients with relapsed/refractory extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT): the HD-K phase II trial.

scientific article published on May 2015

How I treat MALT lymphoma: 'a subjective interpretation of the gospel according to Isaacson….'

scientific article published on 01 July 2020

How I treat neuroendocrine tumours

scientific article published on 01 August 2020

Immunohistochemical expression of cereblon and MUM1 as potential predictive markers of response to lenalidomide in extranodal marginal zone B-cell lymphoma of the mucosa-associated lymphoid tissue (MALT lymphoma).

scientific article

Immunomodulatory treatment for mucosa-associated lymphoid tissue lymphoma (MALT lymphoma)

scientific article published on 29 May 2020

Infection with multidrug-resistant Campylobacter coli mimicking recurrence of carcinoid syndrome: a case report of a neuroendocrine tumor patient with repeated diarrhea

scientific article

Long-term safety and activity of cladribine in patients with extranodal B-cell marginal zone lymphoma of the mucosa-associated lymphoid tissue (MALT) lymphoma

scientific article published on 18 November 2015

Maternal outcome monitoring: induction of labor versus spontaneous onset of labor—a retrospective data analysis

scientific article

Ondansetron for diarrhea associated with neuroendocrine tumors.

scientific article

Plasmacytic differentiation in MALT lymphomas following treatment with rituximab ⬇️

scientific article published on December 22, 2011

Pre- and postoperative treatment modalities for esophageal squamous cell carcinoma.

scientific article

Prevalence of clarithromycin-resistant Helicobacter pylori strains in gastric mucosa-associated lymphoid tissue lymphoma patients

scientific article published on 19 April 2016

Primary mucosa-associated lymphoid tissue (MALT) lymphoma of the liver: clinical, molecular, and microbiological aspects

scientific article published on 04 April 2012

Prolonged follow-up on lenalidomide-based treatment for mucosa-associated lymphoid tissue lymphoma (MALT lymphoma)-Real-world data from the Medical University of Vienna

scientific article published on 28 July 2019

Recent developments in nongastric mucosa-associated lymphoid tissue lymphoma.

scientific article published on December 2011

Retrospective comparison of the effectiveness of various treatment modalities of extragastric MALT lymphoma: a single-center analysis

scientific article published on 15 March 2014

Rituximab plus bendamustine is active in pretreated patients with extragastric marginal zone B cell lymphoma of the mucosa-associated lymphoid tissue (MALT lymphoma)

scientific article

Rituximab plus subcutaneous cladribine in patients with extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue: a phase II study by the Arbeitsgemeinschaft Medikamentose Tumortherapie.

scientific article

Rituximab, Ara-C, dexamethasone and oxaliplatin (R-ADOx) is effective for treatment of elderly patients with relapsed mantle cell lymphoma

scientific article

Running in the family: MALT lymphoma and autoimmune disease in mother and daughter ⬇️

scientific article published on February 15, 2012

Second line chemotherapy in patients with enteropathy-associated T cell lymphoma: a retrospective single center analysis

scientific article published on 26 April 2011

Subcutaneous dissemination pattern in extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue lymphoma.

scientific article

The European Society for Medical Oncology 'Magnitude of Clinical Benefit Scale' field-tested in infrequent tumour entities: an extended analysis of its feasibility at the Medical University of Vienna.

scientific article published on 16 July 2017

The European Society for Medical Oncology Magnitude of Clinical Benefit Scale in daily practice: a single institution, real-life experience at the Medical University of Vienna.

scientific article

The potential evasion of immune surveillance in mucosa associated lymphoid tissue lymphoma by DcR2-mediated up-regulation of nuclear factor-κB.

scientific article

Thirteen-year analyses of medical oncology outpatient day clinic data: a changing field

scientific article published on 01 October 2020

Transformed mucosa-associated lymphoid tissue lymphomas: A single institution retrospective study including polymerase chain reaction-based clonality analysis

scientific article published on 24 May 2019

Treatment of mucosa associated lymphoid tissue lymphoma with a long-term once-weekly regimen of oral azithromycin: Results from the phase II MALT-A trial

scholarly article by Heimo Lagler et al published 19 September 2018 in Hematological Oncology

Underlying autoimmune diseases are not aggravated during treatment with lenalidomide in patients with mucosa-associated lymphoid tissue lymphoma

scientific article published on 07 October 2014

[Medical University of Vienna researcher of the month, May 2014]

scientific article published on 01 May 2014

Paulina is supported by:

About Paulina

Help